Market Overview

UPDATE: Oppenheimer Downgrades Bed Bath & Beyond to Perform on Limited Upside Drivers

Share:
Related BBBY
Baird Comments On Bed Bath & Beyond's First Quarter
Bed Bath & Beyond: KeyBanc Remains Underweight Amid Weak Sales, Margins
Game Plan For The Week - Cramer's Mad Money (6/24/16) (Seeking Alpha)

Oppenheimer reduced its rating on Bed Bath & Beyond (NASDAQ: BBBY) from Outperform to Perform with a reiterated $80 price target.

Oppenheimer commented, "Longer term prospects for the company remain upbeat. Nearer term we are increasingly concerned that the potential for consistent and meaningful sales and earnings upside at BBBY is beginning to wane as recent key product cycles and outsized market share opportunities fade and coupons again emerge as a more significant traffic driver for the chain. Investors are apt to scrutinize more closely sales and gross margin trends than ongoing gains from cost controls or buybacks. BBBY's position as a compelling “housing play” now seems well telegraphed in the market."

Bed Bath & Beyond closed at $70.77 on Monday.

Latest Ratings for BBBY

DateFirmActionFromTo
Jun 2016Credit SuisseMaintainsNeutral
Jun 2016Goldman SachsMaintainsSell
Jun 2016JP MorganMaintainsNeutral

View More Analyst Ratings for BBBY
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (BBBY)

View Comments and Join the Discussion!